We would love to hear your thoughts about our site and services, please take our survey here.
What is being sold is being snapped up as we can see the NASDQ is priced to open around 210 price.
We are still very cheap in the pharm market with such excellent pipeline and today's results.
Hold on as this is still early days . I have held for 6 months and still not selling.
RNS today is just another ticking in the box.
What we know is testing is required to stop the spread of covid 19.. The vaccine does not stop the spread so no passport system.will work only testing to stop new variants coming onto your country..
Nice top up on the dip. Do your own research.
There is a big opportunity coming hence the requirement of liquidity. Excellent news as we can see TILS is now looking at massive growth.
This is like remortgaging to move from a single bedroom too a four bedroom. The future is looking good. The MM will try and hover up shares at this price .
Below SP of 200 is a buy in my books. This is a very volatile stock as if it was trading in AIM ! Could this be on a take over at this price? A real possibility. This was approached at the 490 so who would not look at this again at this price.
Forward order books look strong and no Boatman in the wings pushing the price down.
Now looking at a profit on take up of these options which close tomorrow.
Positive RNS plus points saying ahead of schedule . Great progress has been made and approvals by U.k. organic growers plus looking for other approvals. Rolling on for the next lakes .
Don't loose sight of the move from AIM to Main Market. SP is still cheap! The take up of shares for pension funds.
Ordinary Shares will be admitted to the Official List, commence trading on the Main Market and simultaneously trading will be cancelled on AIM on 21 January 2021 at 07:00 am
Save on having to pay the tax when this gets listed on the main is a nice added bonus now. This gets listed on main next week 21st Jan so good buying opportunity. Some good news soon to come as well. Once it goes to main institutions can buy into pensions pots.as they stay away from AIM .
RNS 22nd October 2020
"The Company is targeting the end of the calendar year for completion of preliminary product evaluations, with full release of the final CE Marked system in Q1 2021 allowing for thorough clinical testing requirements."
We should have some news soon and hope then that translates into sales. Any CE Mark should be positive but I have seen no great movement in the SP unless we have sales.
Topped up at this price. Doubled my holding as the negative news from the lockdown. They have virtual games so gaming goes through the roof. Look at the previous lock down . See this as a bargain and not to be missed. U.k. is still behind the rest of Europe in games rooms. Having started visiting them 5 years ago.
Oh dear, someone has not been doing his home work.
CF is very clear on his presentations on the cash status of the company and even talks of paying out a div.
I like others think I would like the cash to be ploughed back into the company for growth.
I think it's at the bottom IMO . News on vaccine approval should be reported on 28th/29th Dec.
Bought in this morning at this price.
With the pending news "data expected to be available before the end of 2020." following the Brazil trial we could have an early Christmas present. They might release some data stating the indicators and await a full report at a later date in the New Year. I cannot see them holding back on the good news.
L2 are lining up to pile in as they know the news will land soon. IMO